APA (7th ed.) Citation

Takahashi, K., Makita, N., Castañeda-Sanabria, J., Argoubi, R., Nowacki, G., Issa, S., . . . Müllerová, H. (2024). Characteristics of Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol or Other Triple Therapies in Japan. Advances in Therapy, 41(12), 4518-4536. https://doi.org/10.1007/s12325-024-02994-8

Chicago Style (17th ed.) Citation

Takahashi, Koichiro, Naoyuki Makita, Johann Castañeda-Sanabria, Ramzi Argoubi, Grégoire Nowacki, Seham Issa, Isao Matsumoto, Yuri Yoshida, and Hana Müllerová. "Characteristics of Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol or Other Triple Therapies in Japan." Advances in Therapy 41, no. 12 (2024): 4518-4536. https://doi.org/10.1007/s12325-024-02994-8.

MLA (9th ed.) Citation

Takahashi, Koichiro, et al. "Characteristics of Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol or Other Triple Therapies in Japan." Advances in Therapy, vol. 41, no. 12, 2024, pp. 4518-4536, https://doi.org/10.1007/s12325-024-02994-8.